Os comunicados de imprensa são emitidos pela FUJIFILM Corporation no Japão.
A Fujifilm não garante que os produtos constantes destes comunicados de imprensa se encontrem comercialmente disponíveis em todos os países e regiões.
Tenha em atenção que o conteúdo deste website está atualizado à data do comunicado de imprensa e está sujeito a alterações sem aviso prévio. As informações em cada comunicado, incluindo a disponibilidade, especificações, preços e contactos, são os que se encontram no momento da publicação.
- Abr 5, 2023
- Fujifilm unveils the latest development roadmap for the Duvo series of FUJINON broadcast zoom lenses compatible with large sensors
- Mar 23, 2023
- Fujifilm launches “FUJINON HZK25-1000mm”
- Jan 6, 2023
- FUJIFILM Cellular Dynamics Announces License Agreement with Novo Nordisk for the Development of iPSC-Derived Cell Therapies
- Dez 13, 2022
- Fujifilm to Build an Advanced Semiconductor Materials Manufacturing Facility in South Korea
- Nov 22, 2022
- Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility
- Out 19, 2022
- Fujifilm develops “FUJINON HZK25-1000mm”
- Out 6, 2022
- Fujifilm to establish its first Bio-CDMO site in Japan
- Out 3, 2022
- Fujifilm to establish a local subsidiary in South Korea to accelerate business growth of cell culture media
- Set 8, 2022
- Fujifilm announces a strategic investment in a new production facility in Kumamoto Japan to support the fast-growing semiconductor industry
- Jul 6, 2022
- Fujifilm launches FUJIFILM PROJECTOR Z6000
- Jul 1, 2022
- Fujifilm launches world’s first mobile app “FUJIFILM Prescale Mobile” that quantifies pressure based on color development on pressure measurement film
- Jun 30, 2022
- Fujifilm to Invest USD 1.6 billion to enhance and expand its global offering of cell culture manufacturing services
- Jun 8, 2022
- Fujifilm Acquires European Inkjet System Integrator UNIGRAPHICA to Expand Inkjet Integration Business Globally
- Abr 5, 2022
- Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
- Mar 29, 2022
- Fujifilm Completes Acquisition of Shenandoah Biotechnology
- Mar 28, 2022
- Fujifilm Invests in a new manufacturing facility for inkjet pigment dispersions in the U.S.
- Mar 22, 2022
- Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins
- Jan 26, 2022
- Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
- Dez 8, 2021
- Fujifilm Kicks Off Operations at its New, State-of-the-Art Cell Culture Media Manufacturing Facility in Europe
- Dez 1, 2021
- FUJIFILM Irvine Scientific Establishes a Bioprocessing Innovation and Collaboration Center in China (FUJIFILM Irvine Scientific)